Definitions
hemostasis = clot formation at sites of vascular injury
hemorrhage = insufficient hemostasis
thrombosis = clot formation outside sites of vascular injury
Steps of Normal Hemostasis
arteriolar vasoconstriction
primary hemostasis
secondary hemostasis
regulation & fibrinolysis
Arteriolar Vasoconstriction
myogenic spasm
neurogenic pain reflex
local factors (ie endothelin)
microvasculature: thromboxane A2
Primary Hemostasis = formation of a weak platelet plug; disorders produce petechia, purpura, mucosal bleeding
activation
most potent incl. thrombin and subendothelial collagen
less potent incl. ADP
adhesion: damaged endothelium releases vWF → binds
subendothelial collagen
platelet GP1b (deficiency = Bernard-Soulier syndrome)
secretion: many factors are secreted, most importantly incl.
dense granules → ADP
alpha granules → P-selectin
platelets → thromboxane A2 (TxA2)
aggregation: fibrinogen/fibrin cross-links platelets
binds GP2b/3a (deficiency = Glanzmann thrombasthenia)
also binds wWF (retracts clot)
pro-coagulation
activation exposes phospholipid esp. phosphatidylserine
coagulation complexes assemble on platelet surface
Secondary Hemostasis = fibrin deposition onto a platelet plug; disorders produce hematomas and hemarthroses
intrinsic pathway: 12 → 11 → 98 → 10
initiated by any of: collagen, kallikrein, HMWK
monitored by PTT (longer pathway, more letters) or anti-F10 level
8 is a cofactor for 9
8 is the only factor produced outside the liver (by endothelium)
extrinsic pathway: 7 → 10
initiated by tissue factor aka thromboplastin
monitored by PT (shorter pathway, less letters) or INR
common pathway: 105 → 2 (thrombin) → 1 (fibrin)
5 is a cofactor for 10
thrombin has many roles
pro-coagulation (damaged endothelium)
activates fibrinogen → fibrin monomers
activates 13 → cross-links fibrin monomers
positive feedback to 11, 8, 5
platelet activation: via PAR-1
pro-inflammation: via other PARs
anti-coagulation (healthy endothelium)
Regulation & Fibrinolysis
regulation: healthy endothelium is the most important hemostatic agent
shields subendothelial collagen, tissue factor, vWF
produces a variety of anti-platelets and anti-coagulants
thrombomodulin-epithelial protein C receptor (TM-EPCR): binds thrombin → CS → APC → ↓5 and 8
prostacyclin (PGI2) & nitric oxide (NO): antiplatelet effects, regulated by flow
ADPase: degrades platelet activator ADP
heparins: activate anti-thrombin 3 (ATIII) → ↓thrombin, 10, 9, 11, 12
tissue plasminogen activator (t-PA): activates plasmin
tissue factor pathway inhibitor (TFPI): inhibits tissue factor
α2-antiplasmin & plasmin activator inhibitor (PAI): inhibit t-PA
fibrinolysis = degradation of cross-linked fibrin
t-PA → plasmin → fibrin degradation products (FDPs) incl. D-dimer